RCTs rarely mention drug costs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.612, 2010-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer drug costs discussed

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences

By Rappange David R.

PharmacoEconomics, Vol. 27, Iss. 12, 2009-12 ,pp. : 1031-1044

Adis International

Access to resources Recommend Favorite

COPD costs depend on disease severity, drug therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Prescription drug costs are expected to rise by > 18%

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 249, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Loss of bodyweight reduces drug use, costs in obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite